Companies /Industrials

Arxis, Inc. Class A Common Stock

NASDAQ: ARXS Aerospace & Defense
$48.46
▼ $3.06 (−5.94%) today
Markets closed · 8:39am ET

ARXS at a Glance

Valuation
Market cap
$20.9B
P/E ratio
269.2
Profitability
Revenue (TTM)
$1.9B
Profit margin
11.6%
EPS (TTM)
$0.18
Price
52-week range
$33 – $62
Street target
$66.50

Headquartered in Bloomfield, CT Fiscal year ends December NASDAQ: ARXS arxis.com

About Arxis

Arxis, Inc. designs and manufactures proprietary, mission-critical electronic and mechanical engineered components. It serves three end markets: aerospace and defense (Defense & Space and Commercial Aerospace), medical technology, and specialized industrial markets (Industrial Technology). It reports through two segments, Electronic Components and Mechanical Components. The company relies on its intellectual property and engineering capabilities to supply components for customers' complex performance needs, including suppliers to U.S. government programs. Arxis grows organically and through an active acquisition program. In 2026 it acquired six businesses: Omnetics Connector Corporation (high-reliability Micro-D-Sub and Nano-D-Sub connectors and interconnect systems), Schatz Bearing (precision bearings for aerospace, defense and industrial uses), StratEdge (ceramic packages for high-frequency, high-power electronics), Micro-Tronics, MagCanica and Blue Line. Arxis completed its IPO and corporate reorganization in April 2026 and trades on Nasdaq under ARXS. It has Class A and Class B common stock outstanding and remains a portfolio company of private investment firm Arcline Investment Management. Updated

ARXS Coverage

Frequently Asked Questions

What does Arxis do?

Arxis, Inc. designs and manufactures proprietary, mission-critical electronic and mechanical engineered components. It serves three end markets: aerospace and defense (Defense & Space and Commercial Aerospace), medical technology, and specialized industrial markets (Industrial Technology).

What is the ARXS stock price target?

The Wall Street consensus 12-month price target for ARXS is $66.50.